Skip to main content

The Osterholm Update: COVID-19 Podcast  [47]

Persistent link to this collection: https://hdl.handle.net/11299/218334

A weekly report on the COVID-19 pandemic from infectious disease expert Michael Osterholm, PhD, MPH. Dr. Osterholm is the director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota and has spent a career investigating outbreaks. Since 2005, he has emphasized supply chain and other vulnerabilities and a critical need for pandemic preparedness. In this podcast, Dr. Osterholm dissects the latest COVID-19 news, data, and guidance.

This podcast is available at https://www.cidrap.umn.edu/covid-19/podcasts-webinars.


Recently Added

Episode 43: A Realist Adjusts the Sails

Osterholm, Michael; Dall, Chris (2021-02-11)
In this episode, Dr. Osterholm and host Chris Dall discuss the current trajectory of the pandemic and inconsistent public health messaging in the US, the latest information on variants and considerations for prioritizing ...

Episode 42: Calling an Audible

Osterholm, Michael; Dall, Chris (2021-02-04)
In this episode, Dr. Osterholm and host Chris Dall discuss the latest challenges related to variants of concern, the case for delaying second doses of current vaccines to broaden access to first doses, and double masking.

Episode 41: Surrender Is Not an Option

Osterholm, Michael; Dall, Chris (2021-01-28)
In this episode, Dr. Osterholm and host Chris Dall discuss the issue of opening schools, updates on variants of concern, and more news on vaccines and their distribution.

Episode 40: An Imperfect Storm

Osterholm, Michael; Dall, Chris (2021-01-21)
In this episode, Dr. Osterholm and host Chris Dall discuss the latest information on SARS-CoV-2 variants, estimates as to just how much of the US population might have some immunity to the virus, and the current supply and ...

Episode 39: Places We've Never Been Part 2

Osterholm, Michael; Dall, Chris (2021-01-14)
In this episode, Dr. Osterholm and host Chris Dall discuss the shifting baseline of COVID-19 in the US, the latest information on SARS-CoV-2 variants of concern, continued challenges complicating vaccine distribution, and ...

View more